Centene traded at $60.99 this Thursday October 1st, decreasing $1.13 or 1.82 percent since the previous trading session. Looking back, over the last four weeks, Centene lost 9.43 percent. Over the last 12 months, its price rose by 65.64 percent. Looking ahead, we forecast Centene to be priced at 60.48 by the end of this quarter and at 56.65 in one year, according to Trading Economics global macro models projections and analysts expectations.
Centene Corporation is a multi-national healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It also provides education and outreach programs to inform and assist members in accessing appropriate healthcare services. It operates through two segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through government subsidized and commercial programs. Its Specialty Services segment includes companies offering diversified healthcare services and products to its Managed Care segment and other external customers. It provides a range of healthcare products and services, primarily through Medicaid, Medicare and commercial products.